Announced Thu, 14 May · 14:18 IST

The Board has fixed Friday, July 03, 2026, as the "Record Date" to ascertain the eligibility of the shareholders for the payment of final cum special dividend.

Record Date RevisedCorporate Actions View source PDF

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.3%1-day move
₹540.00
prior close
₹532.95
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-1.0-0.7-0.9-4.3-4.8-3.7-5.1-3.1-3.5+2.4+14.6+27.2
Up moveDown movePending
AI summary

Akums Drugs and Pharmaceuticals has fixed July 3, 2026 as the record date for determining shareholder eligibility to receive dividend. The Board has recommended a final dividend of Rs. 1.00 per share (50% on face value of Rs. 2) and a special dividend of Rs. 2.00 per share (100%), totaling Rs. 3 per share for FY2026. This is subject to shareholder approval at the 22nd AGM scheduled for July 10, 2026, and payment will be made within 30 days of that approval. For context, standalone profit after tax declined to Rs. 1,116.40 million in FY2026 from Rs. 1,609.98 million in FY2025, with EPS falling from Rs. 10.76 to Rs. 7.29. This appears to be the company's first dividend since its IPO in August 2024.

Likely market impact

Shareholders holding shares on July 3, 2026 will receive Rs. 3 per share, providing direct cash return. The dividend declaration is positive for investor sentiment, though the company saw significant profit decline year-on-year.